YANG Liying | Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
スポンサーリンク
概要
- 同名の論文著者
- Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto Universityの論文著者
関連著者
-
Kawakami Koji
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Kawakami Koji
Department Of Otorhinolaryngology Yokohama City University School Of Medicine
-
HORIBE Tomohisa
Department of Bioscience & Technology, Faculty of Science & Engineering, Ritsumeikan University
-
KOHNO Masayuki
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
YANG Liying
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
Yang Liying
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Kohno Masayuki
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Horibe Tomohisa
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Kohno Masayuki
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University:department Of R & D Promotion Upstream Infinity Inc.
-
Ohara Koji
Department Of Microbiology Tokyo College Of Pharmacy
-
Ohara Koji
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
UEYAMA Hanae
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
NAKAJIMA Oumi
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
Ueyama Hanae
Department Of Pharmacology Graduate School Of Medicine And Public Health Kyoto University
-
Nakajima Oumi
Department Of Pharmacology Graduate School Of Medicine And Public Health Kyoto University
-
Nakajima Oumi
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University
著作論文
- Characterization of a novel Neuropilin-1 targeted hybrid peptide disintegrating cancer cell membrane
- Effective in vitro and in vivo Antitumor Activity of Hybrid IL4-lytic Peptide